Rubicon Organics Reports Third Quarter Financial Results and Operational Milestones

Published: November 26, 2020

Rubicon Organics Reports Third Quarter Financial Results and Operational Milestones

Rubicon Organics Inc. reported its financial results for the third quarter ended September 30, 2020 (Q3 2020). All amounts are expressed in Canadian dollars.

“The net revenue increase we delivered in Q3 2020 is only the beginning of Rubicon Organics demonstrating its potential,” said Jesse McConnell, Chief Executive Officer. “We have been operating at full capacity for six months now, and more and more Simply BareTM Organic product continues to hit the shelves across the country with customers and cannabis connoisseurs giving strong endorsements of our super-premium organic products. Our journey is only going to get more exciting from here. We have invested in world class personnel that will help bring new brands and products to market that will capture the desire of consumers to drive our growth in revenue and profitability.”

Q3 2020 Highlights :

  • Earned $3.2 million of net revenue, an increase of $2.2 million or 219% as compared to Q2 2020;
  • Entered into a brand licensing agreement with Wildflower Brands Inc. (CSE:SUN) for the production of Wildflower-branded CBD Relief Sticks and CBD Cool Sticks in Canada;
  • Commenced trading on the TSX Venture Exchange on September 22, 2020;
  • Entered into a distribution agreement with PAX LABS®, Inc. subsequent to quarter-end to launch pods for the closed-loop PAX® ERA™ system under its Simply Bare™ Organics brand;
  • Signed a cannabis 2.0 product distribution agreement subsequent to quarter-end with Canada House Wellness Group Inc. (CSE: CHV) for the distribution Rubicon Organics’ line of concentrate products;
  • Completed the amalgamation of subsidiaries which allows for over $20 million of tax losses to be applied against future profits; and
  • On November 16, 2020, announced the acceleration of the warrant expiry date for 3.1 million warrants at an exercise price of $3.50 per share.

Q3 2020 Select Financial and Operational Results :

For the three months ended
September 30, 2020
2020 2019
$ $
Gross revenue 3,725,367
Net revenue 3,166,786
Other income 491,405
Loss from continuing operations (4, 279,330 ) (2,776,605 )
Loss from discontinued operations (37,918 ) (1,677,848 )
Net loss for the period (4, 317,248 ) (4,454,453 )
Total comprehensive loss (4, 187,147 ) (4,299,700 )
Adjusted EBITDA ( 2,576,373 ) (2,542,130 )
Loss per share from continuing operations (0.09 ) (0.07 )
Loss per share (0.09 ) (0.12 )

In Q3 2020, Rubicon Organics earned $3.2 million of net revenue which is an increase of $2.2 million or 219% as compared to the second quarter Q2 2020. This increase in net revenue is attributable to higher sales volume through direct sales to provincial suppliers and under the Agro-Greens Agreement.

The Company reported an Adjusted EBITDA loss of $2.6 million in Q3 2020, as compared to a loss of $2.5 million in Q2 2020 and a loss of $2.5 million in the prior year. The sequential change in Adjusted EBITDA is attributable to the increase in net revenue in Q3 2020, offset by additions to senior personnel and compensation across the organization, and general and administrative expenses.

The Company reported a net loss of $4.3 million in Q3 2020, as compared to a net loss of $1.8 million in Q2 2020 and net loss of $4.5 million in the prior year. The sequential change in profitability reflects fair value changes in the Company’s cannabis assets and the variance relative to Q3 2019 reflects the increase to net revenue offset by the impact of fair value changes on cannabis assets and discontinued operations.


Rubicon Organics is focused on building its portfolio of premium brands in the Canadian market that is anchored by its flagship Simply BareTM Organic cannabis brand. The Company intends to launch additional brands into the market in both the flower and extract categories, along with a diverse portfolio of cannabis 2.0 products. The Company has also established distribution channels to Germany with the expectation to enter international markets in 2021.

The Company has direct supply agreements with the OCS, BCLDB and AGLC and has recently signed with the SQDC. The Company expects to ramp up product deliveries to these markets as well as initiate product shipment to Quebec in December 2020. The Company plans to continue to use local distributors in Saskatchewan and Manitoba.

Following approval from Health Canada on May 5, 2020 for site amendments that included the use of its land at the Delta Facility for an outdoor grow, the Company launched a pilot scale outdoor grow. Following on from the lessons of this pilot scale program, the Company is assessing the scale and viability of a larger outdoor grow program in 2021.

The Company has installed additional high-performance LED lighting in the final three of its five flowering compartments to increase quality and yield throughout the year. The Company is performing an assessment of areas for additional capital expenditure which would increase throughput and efficiency. Renovations to the Delta Facility’s processing area are underway to facilitate compliance with EU-GMP requirements thereby providing access to the German market through the Company’s supply agreement with Canacur GmbH. The Company has developed an extensive product innovation pipeline and is preparing to bring the first phase of those products to market.

The Company is determined to achieve positive operating cash flow and profitability. The Company currently expects to achieve positive adjusted EBITDA on a monthly basis by year-end 2020 and to achieve monthly positive cash flow from operations in the first half of 2021. The Company expects to generate significant operating leverage by maintaining moderate increases in production costs and operating expenses, with linear increases in inventory expensed to costs of sales relative to net revenue, but at a lower per unit cost.

The Company expects to refinance debt maturing in 2021 to a long-term mortgage financing facility, potentially with more favourable terms, and may seek other capital through equity, and other debt arrangements.

The COVID-19 outbreak was declared a pandemic by the World Health Organization in 2020. The situation is dynamic and the ultimate duration and magnitude of the impact on the economy and our business are not known at this time. These impacts could include an impact on our ability to maintain operations, to obtain debt and equity financing, access to necessary supplies, credit risk associated with our accounts receivable, impairments in the value of our long-lived assets, or potential future decreases in revenue or the profitability of our ongoing operations. The Company continues to work diligently to ensure operations continue and product is delivered while continuing to emphasize the safety of our product and employees.

Recent News

View All News Items

Latest Article

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

High Spirits and Higher Sales: Cannabis Seen as a Staple During the Holidays

As the holiday season approaches, consumers across Canada are gearing up for festivities and gift-giving. While traditional retail industries have long capitalized on holiday consumer spending habits, the cannabis market is quickly establishing itself as a key player in this annual economic surge.

Read Article